ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
1,787
Screening encounters
1,912
Diagnostic referrals
354
Outstanding pathways
151

Screening pathway

  1. Screening1,912Encounters
  2. Positive finding637Documented findings
  3. Referral354Diagnostic referrals
  4. Follow-up394Diagnostic visits
  5. Outcome203Resolved pathways

Stage totals use different units. Pending pathways: 151. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0652 · EXP-0652Synthetic · Site A

Full participant history through 2025-11-17, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2025-08-17
  4. · Diagnostic referral · EXP-0652-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Barrier documented · Appointment coordination
  8. · Barrier documented · Contact difficulty
  9. · Diagnostic visit · Missed
  10. · Diagnostic booking · Rebooking
  11. · Navigation intervention · Coordination support
  12. · Diagnostic visit · Attended
  13. · Diagnosis · Colposcopy · Biopsy collected
  14. · Diagnosis · Histopathology · No high-grade lesion identified
  15. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-05-05
  16. · Follow-up disposition · Resolved · EXP-0652-T-R
  17. · Screening · HPV DNA · Repeat · Prior VIA positive
  18. · Screening result · HPV DNA · HPV not detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

1787 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0658 · Expanded synthetic participant 0658Site C — Rural Outreach Programme
EXP-0660 · Expanded synthetic participant 0660Site B — Peri-Urban Access Programme
EXP-0661 · Expanded synthetic participant 0661Site C — Rural Outreach Programme
EXP-0666 · Expanded synthetic participant 0666Site C — Rural Outreach Programme
EXP-0672 · Expanded synthetic participant 0672Site D — Community Engagement Programme
EXP-0674 · Expanded synthetic participant 0674Site E — Resource-Constrained Navigation Programme
EXP-0686 · Expanded synthetic participant 0686Site B — Peri-Urban Access Programme
EXP-0688 · Expanded synthetic participant 0688Site E — Resource-Constrained Navigation Programme
EXP-0689 · Expanded synthetic participant 0689Site D — Community Engagement Programme
EXP-0692 · Expanded synthetic participant 0692Site A — Urban Referral Hub
EXP-0695 · Expanded synthetic participant 0695Site A — Urban Referral Hub
EXP-0700 · Expanded synthetic participant 0700Site B — Peri-Urban Access Programme
EXP-0702 · Expanded synthetic participant 0702Site D — Community Engagement Programme
EXP-0704 · Expanded synthetic participant 0704Site A — Urban Referral Hub
EXP-0705 · Expanded synthetic participant 0705Site E — Resource-Constrained Navigation Programme
EXP-0707 · Expanded synthetic participant 0707Site A — Urban Referral Hub
EXP-0711 · Expanded synthetic participant 0711Site E — Resource-Constrained Navigation Programme
EXP-0714 · Expanded synthetic participant 0714Site B — Peri-Urban Access Programme
EXP-0716 · Expanded synthetic participant 0716Site C — Rural Outreach Programme
EXP-0721 · Expanded synthetic participant 0721Site A — Urban Referral Hub
EXP-0722 · Expanded synthetic participant 0722Site E — Resource-Constrained Navigation Programme
EXP-0723 · Expanded synthetic participant 0723Site C — Rural Outreach Programme
EXP-0726 · Expanded synthetic participant 0726Site B — Peri-Urban Access Programme
EXP-0727 · Expanded synthetic participant 0727Site C — Rural Outreach Programme
EXP-0730 · Expanded synthetic participant 0730Site C — Rural Outreach Programme

Programme insights

Encounters by modality

VIA
816
HPV DNA
823
Cytology
273

Navigation activity

Barrier documented
292
Contact attempt
519
Navigation intervention
123
Diagnostic booking
433
Diagnostic visit
394

Documented barriers

Contact difficulty
89
Transport difficulty
100
Appointment coordination
103

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.